Michael King
Stock Analyst at EF Hutton
(1.00)
# 3,642
Out of 4,761 analysts
126
Total ratings
34.15%
Success rate
-16.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael King
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLM Apollomics | Maintains: Buy | $1,100 → $650 | $7.02 | +9,159.26% | 4 | Apr 1, 2024 | |
| SONN Sonnet BioTherapeutics Holdings | Assumes: Buy | $1,179 | $1.44 | +81,788.89% | 7 | Aug 23, 2023 | |
| LTRN Lantern Pharma | Reiterates: Buy | $11 | $4.33 | +154.04% | 10 | Aug 10, 2023 | |
| BMEA Biomea Fusion | Reiterates: Buy | $32 | $3.46 | +824.86% | 11 | Jun 26, 2023 | |
| JSPR Jasper Therapeutics | Reiterates: Buy | $69 | $5.96 | +1,049.33% | 10 | Jun 12, 2023 | |
| COEP Coeptis Therapeutics Holdings | Assumes: Buy | $200 | $10.52 | +1,801.14% | 7 | May 25, 2023 | |
| HOWL Werewolf Therapeutics | Assumes: Buy | $8.3 | $1.38 | +501.45% | 6 | May 25, 2023 | |
| REGN Regeneron Pharmaceuticals | Reiterates: Buy | $862 | $700.33 | +23.08% | 11 | May 1, 2023 | |
| EXEL Exelixis | Reiterates: Buy | $24 | $36.85 | -34.87% | 10 | Apr 28, 2023 | |
| OCEA Ocean Biomedical | Maintains: Buy | $10 → $17 | $0.13 | +13,328.12% | 3 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $166 | $3.32 | +4,900.00% | 8 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $15.74 | +166.84% | 5 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $304 | $250.59 | +21.31% | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $116 | $12.17 | +853.16% | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.92 | +252.74% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $560 | $1.24 | +45,061.29% | 2 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $37.70 | -36.34% | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,000 → $800 | $1.34 | +59,601.49% | 2 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $46 | $18.59 | +147.44% | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $96 | $35.22 | +172.57% | 6 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $0.93 | +3,770.97% | 1 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.61 | +1,875.63% | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $8.00 | +287.50% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $180 → $160 | $0.17 | +91,695.75% | 4 | Oct 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $33 → $36 | $644.48 | -94.41% | 2 | Nov 13, 2017 |
Apollomics
Apr 1, 2024
Maintains: Buy
Price Target: $1,100 → $650
Current: $7.02
Upside: +9,159.26%
Sonnet BioTherapeutics Holdings
Aug 23, 2023
Assumes: Buy
Price Target: $1,179
Current: $1.44
Upside: +81,788.89%
Lantern Pharma
Aug 10, 2023
Reiterates: Buy
Price Target: $11
Current: $4.33
Upside: +154.04%
Biomea Fusion
Jun 26, 2023
Reiterates: Buy
Price Target: $32
Current: $3.46
Upside: +824.86%
Jasper Therapeutics
Jun 12, 2023
Reiterates: Buy
Price Target: $69
Current: $5.96
Upside: +1,049.33%
Coeptis Therapeutics Holdings
May 25, 2023
Assumes: Buy
Price Target: $200
Current: $10.52
Upside: +1,801.14%
Werewolf Therapeutics
May 25, 2023
Assumes: Buy
Price Target: $8.3
Current: $1.38
Upside: +501.45%
Regeneron Pharmaceuticals
May 1, 2023
Reiterates: Buy
Price Target: $862
Current: $700.33
Upside: +23.08%
Exelixis
Apr 28, 2023
Reiterates: Buy
Price Target: $24
Current: $36.85
Upside: -34.87%
Ocean Biomedical
Apr 27, 2023
Maintains: Buy
Price Target: $10 → $17
Current: $0.13
Upside: +13,328.12%
Mar 28, 2023
Reiterates: Buy
Price Target: $166
Current: $3.32
Upside: +4,900.00%
Feb 24, 2023
Reiterates: Buy
Price Target: $42
Current: $15.74
Upside: +166.84%
Feb 24, 2023
Reiterates: Buy
Price Target: $304
Current: $250.59
Upside: +21.31%
Feb 24, 2023
Maintains: Buy
Price Target: $123 → $116
Current: $12.17
Upside: +853.16%
Dec 16, 2022
Initiates: Buy
Price Target: $10
Current: $2.92
Upside: +252.74%
Mar 30, 2022
Maintains: Buy
Price Target: $500 → $560
Current: $1.24
Upside: +45,061.29%
Mar 23, 2022
Initiates: Buy
Price Target: $24
Current: $37.70
Upside: -36.34%
Mar 11, 2022
Maintains: Buy
Price Target: $1,000 → $800
Current: $1.34
Upside: +59,601.49%
Mar 8, 2022
Maintains: Buy
Price Target: $43 → $46
Current: $18.59
Upside: +147.44%
Mar 3, 2022
Maintains: Buy
Price Target: $98 → $96
Current: $35.22
Upside: +172.57%
Jan 10, 2022
Initiates: Buy
Price Target: $36
Current: $0.93
Upside: +3,770.97%
Dec 23, 2021
Initiates: Buy
Price Target: $12
Current: $0.61
Upside: +1,875.63%
Nov 5, 2021
Maintains: Buy
Price Target: $25 → $31
Current: $8.00
Upside: +287.50%
Oct 18, 2019
Maintains: Market Outperform
Price Target: $180 → $160
Current: $0.17
Upside: +91,695.75%
Nov 13, 2017
Maintains: Market Outperform
Price Target: $33 → $36
Current: $644.48
Upside: -94.41%